Reuters
A daily version of the pill was first approved by the FDA (news - web sites) in 2003, but the companies never launched the product as they explored a more convenient dosage for the medicine to treat brittle bones.
Boniva, known in Europe as Bonviva, is part of a popular class of drugs known as bisphosphonates that aim to treat post-menopausal women with osteoporosis.
More...
|